Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Only 1 Milestone Identified year end completion !

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Oct 06, 2023 11:38am

454 Views

Post# 35673231

RE:RE:Only 1 Milestone Identified year end completion !

They need a PMA for the fibre optic device. Basically its already approved for the trial. Just a formality for final approval of laser activation device used. Takes 180 days but will be required for full approval or AA.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 25, 2024